These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36503035)

  • 1. A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.
    Cope S; Chan K; Campbell H; Chen J; Borrill J; May JR; Malcolm W; Branchoux S; Kupas K; Jansen JP
    Value Health; 2023 Apr; 26(4):465-476. PubMed ID: 36503035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate network meta-analysis of survival function parameters.
    Cope S; Chan K; Jansen JP
    Res Synth Methods; 2020 May; 11(3):443-456. PubMed ID: 32125077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis.
    Wiksten A; Hawkins N; Piepho HP; Gsteiger S
    Value Health; 2020 Jul; 23(7):918-927. PubMed ID: 32762994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network.
    Freeman SC; Cooper NJ; Sutton AJ; Crowther MJ; Carpenter JR; Hawkins N
    Stat Methods Med Res; 2022 May; 31(5):839-861. PubMed ID: 35044255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making.
    Cope S; Jansen JP
    BMC Med Res Methodol; 2013 Dec; 13():147. PubMed ID: 24289277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and existing flexible survival methods for network meta-analyses.
    Heeg B; Garcia A; Beekhuizen SV; Verhoek A; Oostrum IV; Roychoudhury S; Cappelleri JC; Postma MJ; Nicolaas Martinus Ouwens MJ
    J Comp Eff Res; 2022 Sep; ():. PubMed ID: 36093741
    [No Abstract]   [Full Text] [Related]  

  • 8. Bayesian multivariate network meta-analysis model for the difference in restricted mean survival times.
    Tang X; Trinquart L
    Stat Med; 2022 Feb; 41(3):595-611. PubMed ID: 34883534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment for reporting bias in network meta-analysis of antidepressant trials.
    Trinquart L; Chatellier G; Ravaud P
    BMC Med Res Methodol; 2012 Sep; 12():150. PubMed ID: 23016799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysis.
    Mukhopadhyay P; Ye J; Anderson KM; Roychoudhury S; Rubin EH; Halabi S; Chappell RJ
    JAMA Oncol; 2022 Sep; 8(9):1294-1300. PubMed ID: 35862037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies.
    Schulz C; Gandara D; Berardo CG; Rosenthal R; Foo J; Morel C; Ballinger M; Watkins C; Chu P
    Clin Lung Cancer; 2019 Nov; 20(6):451-460.e5. PubMed ID: 31375454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas.
    Petit C; Blanchard P; Pignon JP; Lueza B
    Syst Rev; 2019 Apr; 8(1):96. PubMed ID: 30987679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
    Vickers AD; Winfree KB; Cuyun Carter G; Kiiskinen U; Jen MH; Stull D; Kaye JA; Carbone DP
    BMC Cancer; 2019 Apr; 19(1):353. PubMed ID: 30987609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organised inpatient (stroke unit) care for stroke: network meta-analysis.
    Langhorne P; Ramachandra S;
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000197. PubMed ID: 32324916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model.
    Austin PC; Fang J; Lee DS
    Stat Med; 2022 Feb; 41(3):612-624. PubMed ID: 34806210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma.
    Petersohn S; McGregor B; Klijn SL; May JR; Ejzykowicz F; Kurt M; Dyer M; Malcolm B; Branchoux S; Nickel K; George S; Kroep S
    J Comp Eff Res; 2023 Aug; 12(8):e230004. PubMed ID: 37431849
    [No Abstract]   [Full Text] [Related]  

  • 18. Network meta-analysis of survival data with fractional polynomials.
    Jansen JP
    BMC Med Res Methodol; 2011 May; 11():61. PubMed ID: 21548941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.